{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:13:54Z","timestamp":1794071634448,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM)"},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique (CNRS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut National du Cancer (INCa, Boulogne-Billancourt, France)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ijpharm.2012.02.025","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T10:03:52Z","timestamp":1330077832000},"page":"452-459","source":"Crossref","is-referenced-by-count":194,"title":["Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice"],"prefix":"10.1016","volume":"427","author":[{"given":"H\u00e9lo\u00efse","family":"Ragelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Crauste-Manciet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Brossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy G.","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.02.025_bib0005","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/jn\/130.9.2243","article-title":"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration","volume":"130","author":"Arai","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0010","series-title":"Emulsions: Theory and Practice","article-title":"Technique of emulsification","author":"Becher","year":"1965"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0015","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1529\/biophysj.107.107813","article-title":"Flavonoids affect actin functions in cytoplasm and nucleus","volume":"93","author":"B\u00f6hl","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-8686(03)00115-5","article-title":"Degradation of kinetically-stable o\/w emulsions","volume":"107","author":"Capek","year":"2004","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-009-0217-z","article-title":"Antimetastatic potential of fisetin involves inactivation of the PI3K\/Akt and JNK signaling pathways with downregulation of MMP-2\/9 expressions in prostate cancer PC-3 cells","volume":"333","author":"Chien","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/np50116a009","article-title":"Flavonoids as DNA topoisomerase antagonists and poisons: structure\u2013activity relationships","volume":"58","author":"Constantinou","year":"1995","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2008.01.004","article-title":"Parenteral microemulsions: an overview","volume":"355","author":"Date","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0040","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1461-5347(99)00141-8","article-title":"Top ten considerations in the development of parenteral emulsions","volume":"4","author":"Floyd","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0050","first-page":"2916","article-title":"Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis","volume":"57","author":"Fotsis","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/10915810600961531","article-title":"Nonclinical vehicle use in studies by multiple routes in multiple species","volume":"25","author":"Gad","year":"2006","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2008.04.027","article-title":"Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion","volume":"360","author":"Ganta","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0065","series-title":"Pharmacokinetics","first-page":"409","article-title":"Noncompartmental analysis based on statistical moment theory","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0070","doi-asserted-by":"crossref","first-page":"10545","DOI":"10.1021\/jp0613337","article-title":"Study of the complexation of fisetin with cyclodextrins","volume":"110","author":"Guzzo","year":"2006","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s11095-008-9795-9","article-title":"A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo","volume":"26","author":"Han","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0085","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/S0024-3205(01)01375-3","article-title":"A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin","volume":"69","author":"Hu","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0090","first-page":"341","article-title":"Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatment","volume":"16","author":"Jankun","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(98)00164-3","article-title":"Development of nonionic surfactant\/phospholipid o\/w emulsion as a paclitaxel delivery system","volume":"58","author":"Kan","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-409X(00)00102-2","article-title":"Disposition characteristics of emulsions and incorporated drugs after systemic or local injection","volume":"45","author":"Kawakami","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2007.05.004","article-title":"Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process","volume":"342","author":"Kelmann","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0110","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1158\/0008-5472.CAN-08-0240","article-title":"A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice","volume":"68","author":"Khan","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2188\/jea.8.168","article-title":"Japanese intake of flavonoids and isoflavonoids from foods","volume":"8","author":"Kimira","year":"1998","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-5173(00)00614-1","article-title":"Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment","volume":"212","author":"Kommuru","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/092986710789957760","article-title":"Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids","volume":"17","author":"Leonarduzzi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/1568011023353714","article-title":"Flavonoids as anticancer agents: structure\u2013activity relationship study","volume":"2","author":"Lopez-Lazaro","year":"2002","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/jm049353p","article-title":"Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin","volume":"48","author":"Lu","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0140","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1093\/jn\/135.12.2884","article-title":"Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells","volume":"135","author":"Lu","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0145","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.04.066","article-title":"Development of a liposomal formulation of the natural flavonoid fisetin","volume":"423","author":"Mignet","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0155","first-page":"281","article-title":"Solubilit\u00e9 et constante di\u00e9lectrique","volume":"4","author":"Mulak","year":"1975","journal-title":"Sci. Technol. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2003.09.019","article-title":"SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs","volume":"269","author":"M\u00fcller","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(00)00121-6","article-title":"Lymphatic targeting with nanoparticulate system","volume":"47","author":"Nishioka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2007.07.042","article-title":"Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis","volume":"349","author":"Nornoo","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mrgentox.2005.01.002","article-title":"Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin","volume":"582","author":"Olaharski","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.phrs.2006.10.002","article-title":"Anti-inflammatory activity of fisetin in human mast cells (HMC-1)","volume":"55","author":"Park","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10717540802321792","article-title":"Effect of oil-in-water submicron emulsion surface charge on oral absorption of a poorly water-soluble drug in rats","volume":"15","author":"Poullain-Termeau","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10611860500403156","article-title":"Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion","volume":"13","author":"Reddy","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720105774370267","article-title":"Engineering of nanoemulsions for drug delivery","volume":"2","author":"Sarker","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jss.2008.06.049","article-title":"Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration","volume":"155","author":"Soma","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0210","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1124\/mol.107.034512","volume":"71","author":"Sung","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0215","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cis.2003.10.023","article-title":"Formation and stability of nano-emulsions","volume":"108\u2013109","author":"Tadros","year":"2004","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0225","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/mp8000556","article-title":"Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model","volume":"5","author":"Tagne","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.plipres.2004.09.001","article-title":"Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems","volume":"43","author":"Tamilvanan","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/01635580802521346","article-title":"Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization","volume":"61","author":"Touil","year":"2009","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-010-1505-8","article-title":"Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice","volume":"68","author":"Touil","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1535-7163.MCT-10-0606","article-title":"Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors","volume":"10","author":"Tripathi","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2006.07.023","article-title":"Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs","volume":"115","author":"Wang","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0041-008X(65)90081-5","article-title":"A toxicologic study of dimethyl sulfoxide","volume":"7","author":"Willson","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.02.025_bib0260","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1440-1681.2004.04072.x","article-title":"Vascular and anti-oxidant actions of flavonols and flavones","volume":"31","author":"Woodman","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T17:41:53Z","timestamp":1742578913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0378517312001755"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.025","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}